Kite Pharma

Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
Health

Why Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal

By
January 22, 2018
Iris Network Student
Health

Gene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?

By
November 16, 2017
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
Health

The FDA Just Approved a Second Revolutionary Gene Therapy. A Third Is Probably on the Way

By
October 19, 2017
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
Health

Gilead’s Deal to Buy Kite Pharma Is a Game-Changer

By
August 28, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Fall While Dow Poised To End Streak
Health

Kite Pharma’s Shares Soared Today Thanks to Its Revolutionary Blood Cancer Drug

By
February 28, 2017
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
Health

Why Shares of Next-Gen Cancer Biotech Juno Rallied Today

By
July 14, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health

These Are the Most Promising Experimental Cancer Drugs

By
June 9, 2016

Most Popular